Kelli D. Plunket
GlaxoSmithKline (United Kingdom) · 25 works · 5,607 citations · h-index 20
Top works
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
- Identification of a Chemical Tool for the Orphan Nuclear Receptor FXR
- A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
- Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα
- Functional Consequences of Cysteine Modification in the Ligand Binding Sites of Peroxisome Proliferator Activated Receptors by GW9662
- N-(2-Benzoylphenyl)- l -tyrosine PPARγ Agonists. 1. Discovery of a Novel Series of Potent Antihyperglycemic and Antihyperlipidemic Agents
- Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors
- Identification of a Nonsteroidal Liver X Receptor Agonist through Parallel Array Synthesis of Tertiary Amines
- A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic Activity
- A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
- Effects of troglitazone and metformin on glucose and lipid metabolism
- A Ureido-Thioisobutyric Acid (GW9578) Is a Subtype-Selective PPARα Agonist with Potent Lipid-Lowering Activity
- A Synthetic Triterpenoid, 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO), Is a Ligand for the Peroxisome Proliferator-Activated Receptor γ
- N-(2-Benzoylphenyl)- l -tyrosine PPARγ Agonists. 3. Structure−Activity Relationship and Optimization of the N-Aryl Substituent
- Effects of fenofibrate on lipid parameters in obese rhesus monkeys
- N-(2-Benzoylphenyl)- l -tyrosine PPARγ Agonists. 2. Structure−Activity Relationship and Optimization of the Phenyl Alkyl Ether Moiety
- Synthesis and biological activity of a novel series of indole-derived PPARγ agonists
- Identification of a series of PPARγ/δ dual agonists via solid-Phase parallel synthesis
- Identification of a series of oxadiazole-substituted α-isopropoxy phenylpropanoic acids with activity on PPARα, PPARγ, and PPARδ
- Synthesis and biological activity of l-tyrosine-based PPARγ agonists with reduced molecular weight